Cet article rend compte des travaux d’un workshop organisé conjointement par l’European Federation of Periodontology et la World Heart Federation au cours duquel ont été évaluées les preuves épidémiologiques existantes sur les associations entre maladies parodontales et cardiovasculaires, les liens mécanistiques et l’impact de la thérapie parodontale sur les maladies cardiovasculaires. Cette revue s’est également concentrée sur le risque potentiel et les complications de la thérapie parodontale chez les patients sous traitement anti-thrombotique et a formulé des recommandations pour les dentistes, les médecins et pour les patients visitant les cabinets dentaires et médicaux.
M. Sanz, A. Marco del Castillo, S. Jepsen, J. R. Gonzalez-Juanatey, F. D’Aiuto, P. Bouchard, I. Chapple, T. Dietrich, I. Gotsman, F. Graziani, D. Herrera, B. Loos, P. Madianos, J. B. Michel, P. Perel, B. Pieske, L. Shapira, M. Shechter, M. Tonetti, C. Vlachopoulos, G. Wimmer
Periodontitis and Cardiovascular Diseases. Consensus Report
Periodontitis and Cardiovascular Diseases. Consensus Report. Global Heart. 2020; 15(1): 1. DOI: https://doi.org/10.5334/gh.400 PubMed
Background: In Europe cardiovascular disease (CVD) is responsible for 3.9 million deaths (45% of deaths), being ischaemic heart disease, stroke, hypertension (leading to heart failure) the major cause of these CVD related deaths. Periodontitis is also a chronic non‐communicable disease (NCD) with a high prevalence, being severe periodontitis, affecting 11.2% of the world’s population, the sixth most common human disease.
Material and Methods: There is now a significant body of evidence to support independent associations between severe periodontitis and several NCDs, in particular CVD. In 2012 a joint workshop was held between the European Federation of Periodontology (EFP) and the American Academy of Periodontology to review the literature relating periodontitis and systemic diseases, including CVD. In the last five years important new scientific information has emerged providing important emerging evidence to support these associations.
Results and Conclusions: The present review reports the proceedings of the workshop jointly organised by the EFP and the World Heart Federation (WHF), which has updated the existing epidemiological evidence for significant associations between periodontitis and CVD, the mechanistic links and the impact of periodontal therapy on cardiovascular and surrogate outcomes. This review has also focused on the potential risk and complications of periodontal therapy in patients on anti thrombotic therapy and has made recommendations for dentists, physicians and for patients visiting both the dental and medical practices.
